From Name

From Email

To Name

To Email

Message

Immune Responses to Hepatitis B Vaccination After Hematopoietic Stem Cell Transplantation in Pediatric and Young Adult Patients

from Clinical Transplantation

Immune Responses to Hepatitis B Vaccination After Hematopoietic Stem Cell Transplantation in Pediatric and Young Adult Patients Clinical Transplantation Hematopoietic stem cell transplantation (HSCT) recipients require hepatitis B (HBV) revaccination. Hepatitis B surface antibody (anti‐HBs) seroconversion rates after revaccination range from 64%–79% in these patients. The seroconversion rate and factors associated with non‐seroconversion have not been clearly elucidated in pediatric and young adult recipients after HSCT. READ MORE

more